An Overview and Renewed Emphasis on Ethnopharmacology of Rosemary (Salvia Rosmarinus)
Abstract
Keywords
Supporting Institution
Project Number
References
- Abers, M., Schroeder, S., Goelz, L., Sulser, A., St. Rose, T., Puchalski, K., & Langland, J., (2021). Antimicrobial activity of the volatile substances from essential oils. BMC Complementary Medicine and Therapies, 21, 124. https://doi.org/10.1186/s12906-021-03285-3
- Allegra, A., Tonacci, A., Pioggia, G., Musolino, C., & Gangemi, S., (2020). Anticancer activity of Rosmarinus officinalis L.: Mechanisms of action and therapeutic potentials. Nutrients, 12(6), 1739. https://doi.org/10.3390/nu12061739
- Andrade, J.M., Faustino, C., Garcia, C., Ladeiras, D., Reis, C.P., & Rijo, P., (2018). Rosmarinus officinalis L.: An update review of its phytochemistry and biological activity. Future Science OA, 4(4), FSO283. https://doi.org/10.4155/fsoa-2017-0124
- Bakırel, T., Bakırel, U., Keleş, O.Ü., Ülgen, S.G., & Yardibi, H., (2008). In vivo assessment of antidiabetic and antioxidant activities of rosemary (Rosmarinus officinalis) in alloxan-diabetic rabbits. Journal of Ethnopharmacology, 116(1), 64–73. https://doi.org/10.1016/j.jep.2007.10.039
Details
Primary Language
English
Subjects
Pharmacology and Pharmaceutical Sciences
Journal Section
Review
Publication Date
June 30, 2022
Submission Date
April 4, 2022
Acceptance Date
May 31, 2022
Published in Issue
Year 2022 Volume: 5 Number: 1
Cited By
Deciphering Neuroprotective Effect of Rosmarinus officinalis L. (syn. Salvia rosmarinus Spenn.) through Preclinical and Clinical Studies
Current Drug Targets
https://doi.org/10.2174/0113894501255093240117092328







CUPMAP Journal is licensed under a